Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANGELO HUMBERTO PAREDES

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1235289398
CMS profile
147125
Location
MIDDLETOWN, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$4,119.55

108 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,319.55 104
Consulting Fee $1,800.00 4

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANGELO HUMBERTO PAREDES

NPI 1235289398 · CMS profile ID 147125

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

MIDDLETOWN, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1235289398?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANGELO HUMBERTO PAREDES, NPI 1235289398, CMS profile ID 147125. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1235289398?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ANGELO HUMBERTO PAREDES, NPI 1235289398, CMS profile ID 147125. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1235289398?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ANGELO HUMBERTO PAREDES, NPI 1235289398, CMS profile ID 147125, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1235289398?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

108 matching records · $4,119.55 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 108 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 108.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $15.9107/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025965793 CMS
ABBVIE INC. $1.4307/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071489 CMS
Ardelyx, Inc. $22.3307/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052957515 CMS
Celgene Corporation $18.4807/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015078147 CMS
PFIZER INC. $24.0307/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050524657 CMS
ABBVIE INC. $23.7206/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071487 CMS
NESTLE HEALTHCARE NUTRITION INC. $19.0306/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012440473 CMS
Lucid Diagnostics Inc. $22.6906/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057656771 CMS
Echosens North America, Inc. $300.0006/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052145609 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.4606/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055527402 CMS
INTERCEPT PHARMACEUTICALS, INC. $23.4606/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053806481 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.7506/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057427319 CMS
Regeneron Healthcare Solutions, Inc. $24.9006/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999348675 CMS
Celgene Corporation $2.5506/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015078075 CMS
Gilead Sciences, Inc. $16.9406/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025930813 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.8506/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057195685 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.7406/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057441373 CMS
ABBVIE INC. $16.1306/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071485 CMS
Ironwood Pharmaceuticals, Inc $17.5606/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045557895 CMS
Exact Sciences Corporation $23.5805/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026698779 CMS
Ironwood Pharmaceuticals, Inc $24.3905/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045538907 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.2105/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057420627 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.0905/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055527395 CMS
Echosens North America, Inc. $300.0005/08/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052145603 CMS
Celgene Corporation $21.2705/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015078007 CMS
Mallinckrodt Hospital Products Inc. $32.6205/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042870127 CMS
Gilead Sciences, Inc. $20.6105/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025794079 CMS
ABBVIE INC. $28.6805/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071483 CMS
QOL Medical, LLC $16.4004/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059274577 CMS
Celgene Corporation $24.4804/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015077997 CMS
Echosens North America, Inc. $300.0004/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052145597 CMS
Gilead Sciences, Inc. $16.8104/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025935223 CMS
INTERCEPT PHARMACEUTICALS, INC. $18.4604/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053806477 CMS
Janssen Biotech, Inc. $21.1403/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988395615 CMS
ABBVIE INC. $33.4003/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071481 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.0803/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055527389 CMS
GENZYME CORPORATION $13.2303/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049883859 CMS
ABBVIE INC. $10.0203/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071479 CMS
ABBVIE INC. $22.9403/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071477 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.1103/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057219503 CMS
Ardelyx, Inc. $21.2203/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052957513 CMS
QOL Medical, LLC $22.0203/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059274579 CMS
Echosens North America, Inc. $900.0003/08/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052145591 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.4203/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057181217 CMS
Gilead Sciences, Inc. $14.9303/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025996531 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.2102/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055527385 CMS
INTERCEPT PHARMACEUTICALS, INC. $20.8702/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053806473 CMS
ABBVIE INC. $2.7402/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998071475 CMS
NESTLE HEALTHCARE NUTRITION INC. $18.2002/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012459486 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.0902/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057244115 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $122.62 1
PY2021 $2,123.65 106
PY2022 $2,942.85 146
PY2023 $4,119.55 108
PY2024 $3,133.29 118
PY2025 $10,628.67 110

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $146,934.60 16
PY2022 Principal investigator $165,383.74 18
PY2021 Principal investigator $340,457.86 18
PY2020 Principal investigator $152,516.90 10
PY2019 Principal investigator $474,704.17 28

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

16 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Intercept Pharma Europe Ltd. $2,787.75 12/07/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887305
Principal investigator 1 Intercept Pharma Europe Ltd. $5,617.50 11/22/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887295
Principal investigator 1 Intercept Pharma Europe Ltd. $1,148.04 10/19/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887263
Principal investigator 1 Intercept Pharma Europe Ltd. $1,985.00 10/12/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887273
Principal investigator 1 Intercept Pharma Europe Ltd. $35,730.00 09/14/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887221
Principal investigator 1 Intercept Pharma Europe Ltd. $675.00 09/07/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887233
Principal investigator 1 Intercept Pharma Europe Ltd. $32,693.03 08/10/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887197
Principal investigator 1 Intercept Pharma Europe Ltd. $675.00 07/20/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887177
Principal investigator 1 Intercept Pharmaceuticals, Inc. $11,329.22 06/22/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887511
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,350.00 06/08/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887521
Principal investigator 1 Intercept Pharmaceuticals, Inc. $6,701.19 05/11/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887479
Principal investigator 1 Intercept Pharmaceuticals, Inc. $10,989.00 04/20/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887435
Principal investigator 1 Intercept Pharmaceuticals, Inc. $675.00 04/13/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887445
Principal investigator 1 Intercept Pharmaceuticals, Inc. $12,465.41 04/06/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887411
Principal investigator 1 Intercept Pharmaceuticals, Inc. $4,000.27 03/16/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887389
Principal investigator 1 Intercept Pharmaceuticals, Inc. $18,113.19 02/16/2023 Non-covered Recipient Entity
THE GENEVA FOUNDATION
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1053887337